Skip To Main Content
Eve Brennan on Muck Rack

Eve Brennan

Verified
Dakar
As seen in: Al Jazeera Media Network, CNN, CNN en Español, CNN International, CNN Travel, MSN, MSN Canada, MSN UK, Yahoo Entertainment, Yahoo Life, The Independent (UK) and
freelance journo in Dakar, previous @ajenglish x Doha and @cnni x London / views are my own blah blah / @brennaneve.bsky.social
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Eve

Contact Eve, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Trial begins for new anti-Ebola treatment Original

|
By Eve Brennan Verified
| Arkansas Democrat Gazette Verified
Let us read it for you. Listen now. Your browser does not support the audio element. RWAMPARA, Congo -- More than 250 participants have been enrolled in a trial for a drug that could stop them from contracting Ebola in Congo, in what experts have described as a critical step to try to fight the deadliest outbreak of the disease in the Central African country. The drug is targeted at Bundibugyo virus, which is responsible for the fast-moving outbreak and is without an approved vaccine or treatment.
Open in Who Shared View Duplicates (5) Issue with article?

Inside the study for a remedy to fight Congo's deadliest Ebola outbreak

|
By Eve Brennan Verified
| PBS News Hour - Health
RWAMPARA, Congo (AP) — More than 250 participants have been enrolled in a trial for a drug that could stop them from contracting Ebola in Congo, in what experts have described as a critical step to try to fight the deadliest outbreak of the disease in the Central African country. The drug is targeted at Bundibugyo virus, which is responsible for the fast-moving outbreak and is without an approved vaccine or treatment.
Open in Who Shared View Duplicates (222) Issue with article?

Inside the study for a remedy to fight Congo's deadliest Ebola outbreak

|
By Eve Brennan Verified
| The Register-Herald Verified
RWAMPARA, Congo (AP) — More than 250 participants have been enrolled in a trial for a drug that could stop them from contracting Ebola in Congo, in what experts have described as a critical step to try to fight the deadliest outbreak of the disease in the Central African country. The drug is targeted at Bundibugyo virus, which is responsible for the fast-moving outbreak and is without an approved vaccine or treatment.
Open in Who Shared Issue with article?
See all 2,814 licensed articles (2,830 Total)